Your basket is currently empty!
Sunitinib and Sorafenib trial in locally advanced renal cell carcinoma
Currently the targeted therapy drugs Sunitinib and Sorafenib are widely used in the UK for use in metastatic renal ...
News Archive
Clinical Trials
Molecular markers to PREDICT drug response in kidney cancer patients
(ongoing until 2015)
Are you interested in taking part in a clinical trial in London investigating the use of ...
Standard vs Modified Drug Therapy in Renal Cancer
A randomised multi stage, phase II/III trial of Standard first-line therapy (sunitinib or pazopanib) comparing ...
An Open Label Randomized Phase II Study Comparing Azd2014 Versus Everolimus In Patients With Advanced Metastatic Renal Cancer And Progression On VEGF Targeted Therapy
The study is a randomised trial allowing us to quantify the benefit and potential for further development of ...
Chemotherapy Before and After Surgery in Treating Children With Wilm’s Tumour
Phase III trial to study the effectiveness of chemotherapy before and after surgery in treating children who have ...
A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther)
The purpose of this study is to investigate if 14 weeks of pazopanib therapy prior to surgery (nephrectomy) is of ...
An Open Label Randomized Phase II Study Comparing Azd2014 Versus Everolimus In Patients With Advanced Metastatic Renal Cancer And Progression On VEGF Targeted Therapy
The study is a randomised trial allowing us to quantify the benefit and potential for further development of ...
Novel Prognostic Markers in Renal Cancer
Royal Marsden NHS Foundation Trust is working on the profiling of the expression of signal transduction ...
MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer
This randomized phase II trial is studying MRI scans of blood vessel changes caused by bevacizumab to see how well ...
